CME GROUP INC.
For the period ended Sep 30, 2025. Filed Oct 24, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
| ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
|---|
Issuer Purchases of Equity Securities
| Period · Total Number ofClass AShares Purchased · Average PricePaid per Share · Total Number of Class A Shares Purchased asPart of Publicly Announced Plans or Programs (1) · Maximum Approximate Value of Shares ThatMay Yet Be PurchasedUnder the Plans or Programs(1)(in millions) | ||||||
|---|---|---|---|---|---|---|
| July 1 to July 31 | 58 | $274.64 | — | $2,991.8 | ||
| August 1 to August 31 | 3,860 | 273.91 | — | 2,991.8 | ||
| September 1 to September 30 | 83,585 | 259.14 | — | 2,991.8 | ||
| Total | 87,503 | (2) | — | |||
(1)On December 5, 2024, CME Group announced that its board of directors approved a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class A common stock, par value $0.01 per share (the common stock). The share repurchase program has no expiration date.
(2)Shares purchased consist of shares surrendered to satisfy employee tax obligations upon the vesting of restricted stock.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.